Effects of a Specific Substance in Smokers

Part of paid clinical trials in Portland, Oregon.

Sponsor
Oregon Health and Science University
Study ID
NCT04281979
Status
Recruiting

Conditions

  • Smoking

Eligibility Criteria

Sex
ALL
Age
21 Years - 40 Years
Healthy Volunteers
Accepted

Interventions

  • Study Agent — DRUG
    The study agent will be administered via beverages and/or a capsule. The substances used in the study are legal, non-prescription, and are proven safe for human consumption at the doses used. The study agent may be a depressant (such as alcohol), a stimulant (such as caffeine), or an analgesic (such as aspirin).
  • Placebo — DRUG
    In the placebo conditions participants will consume beverages and capsules that contain no or very small quantities of the study agent.

Study Details

Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the behavioral, psychological and neurobiological factors that contribute to cigarette use in nondaily smokers to aid the development of tailored evidence-based interventions.

Key Dates

Start date
Feb 25, 2020
Status verified
Jul 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Study Agent
  • Placebo Comparator: Placebo

Primary Outcome Measure

Impulsivity [ Time Frame: Immediately after beverage/capsule consumption ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health and Science UniversityPortlandOregon97239
Angelica M Morales, PhD
8186794828

Find similar trials in Portland, OR

Related Studies